agilon health (AGL) Stock

NYSE / Healthcare / Medical Care Facilities

$113.07

−0.62% Close Nov 6

AGL stock daily candlestick chart with 50, 150 and 200-day moving averagesOpen interactive chart
One year of daily prices through the Nov 6, 2026 close. This page updates by about 4 AM ET after each trading day. The interactive chart has the full history.

AGL stock price and performance

AGL stock closed at $113.07 on Nov 6, 2026. The tables below use that final daily session.

Last close
$113.07
Day range
$106.34 to $116.77
52-week range
$7.48 to $133.04
From 52-week high
−15.0%
Average volume (50 days)
221,506
1 week
+33.6%
1 month
+33.5%
3 months
+16.8%
Year to date
+556.4%
1 year
+499.8%
3 years
−73.2%
5 years
−81.5%

Is AGL stock in an uptrend?

Yes, AGL stock is in an uptrend: 1 of the 2 Daily Pivot Breakout momentum filters is active, although it does not meet the Minervini Trend Template criteria. Price is above its 200-day moving average.

Daily Pivot momentum filters
1 of 2 active
100-day ROC
−0.2% filter at 40%: off
100-day EMA slope
+71.7% filter at 25%: active
Trend state
Uptrend
Minervini Trend Template
Not met on the latest scan
50-day average
Above
150-day average
Above
200-day average
Above
200-day slope (1 month)
+12.29%
ATR (14) % of price
6.79%

Momentum filters from the Daily Pivot Breakout indicator: 100-day rate of change and 100-day EMA slope, each against its minimum.

Is AGL stock in a Stage 2 uptrend?

Yes, AGL stock is in a Stage 2 uptrend by our Weinstein stage analysis: its price is above a rising 30-week moving average and it is outperforming SPY.

Weinstein stage
Stage 2 (advancing)
30-week SMA
$88.57
30-week slope (4 weeks)
+13.79%
Mansfield RS vs SPY
96.82
Weeks in Stage 2
1

Weinstein stage analysis uses weekly closes against the 30-week moving average and Mansfield relative strength versus SPY. See the free Stage 2 stocks screener.

AGL support and resistance levels

LevelPriceFrom close
9-day EMA$98.08−13.3%
Daily Pivot resistance (pivot high)$94.37−16.5%
21-day EMA$92.72−18.0%
30-week SMA$88.57−21.7%
50-day SMA$88.28−21.9%
150-day SMA$84.45−25.3%
Latest Daily Pivot low$72.16−36.2%
200-day SMA$66.85−40.9%

Levels above the close act as resistance, levels below as support. Last close $113.07.

AGL breakout and scanner signals

ScannerLast signal (free view, 5 sessions late)Past year
VCPNone in the last year0
RSI DivergenceSep 11, 20263
Weinstein Stage AnalysisOct 19, 2026113
Daily Pivot BreakoutJul 17, 20262
Minervini Trend TemplateAug 5, 202631
Episodic PivotMay 7, 20261
Ichimoku TK crossOct 15, 20264
9/21 EMA crossOct 19, 20264
Golden / Death CrossMay 13, 20261
RS RatingOct 22, 2026116

AGL seasonality by month

  1. Jan+7.9%60% up
  2. Feb−2.5%40% up
  3. Mar+5.9%60% up
  4. Apr+42.8%40% up
  5. May+33.4%67% up
  6. Jun+6.3%83% up
  7. Jul−2.6%50% up
  8. Aug−17.1%0% up
  9. Sep−7.5%33% up
  10. Oct−12.0%33% up
  11. Nov−19.8%0% up
  12. Dec+5.9%60% up

Average monthly return over 5+ years of stored daily closes, and the share of years each month closed higher.

AGL earnings history

ReportedEPS estimateEPS actualSurprise
Nov 4, 2026$-1.47$1.97+234.0%
Aug 5, 2026$0.27$2.15+696.3%
May 22, 2026$1.34$1.78+32.8%
May 6, 2026$0.93$2.32+149.5%
Feb 25, 2026$-6.85$-8.95−30.7%

AGL bull and bear case

What looks strong

  • Stage 2 uptrend by our Weinstein stage analysis scanner.
  • 1 of 2 Daily Pivot momentum filters is active (100-day ROC -0.2%, 100-day EMA slope 71.7%).
  • The 50, 150 and 200-day averages are stacked in uptrend order.
  • Price is above a rising 200-day moving average.
  • Price closed above its Daily Pivot resistance level.

What looks weak

  • Does not meet the Minervini Trend Template on the latest scan.
  • Net income over the last 12 months is negative.
  • Beta is 3.11, so the stock has moved much more than the market.

Drawn only from the data on this page. Not a recommendation.

AGL news and SEC filings, last 30 days

Source: SEC EDGAR.

AGL insider trading and risks

Risk flags from the data

  • Net income over the last 12 months is negative.
  • Beta is 3.11, so the stock has moved much more than the market.

Insider trades: SEC Form 4 open-market purchases and sales.

AGL valuation and fundamentals

Market cap
$1.90B
Enterprise value
$1.70B
P/E (trailing)
-4.8
P/E (forward)
48.0
PEG
0.04
Price to sales
0.32
Price to book
6.78
EV to EBITDA
-19.8
Gross margin
+7.2%
Operating margin
+1.8%
Profit margin
−1.5%
Return on equity
−36.2%
Revenue (TTM)
$6.00B
Revenue growth (quarter, y/y)
+5.9%
Cash
$239.8M
Debt
$33.4M
Beta
3.11
Fiscal yearRevenueNet incomeFree cash flow
2025$5.93B−$391.3M−$105.8M
2024$6.06B−$260.1M−$75.2M
2023$4.32B−$262.8M−$197.0M
2022$2.39B−$106.9M−$118.9M

AGL dividends and splits

Dividend yield
0.00%

Stock splits: 1-for-25 split on Mar 31, 2026.

Who owns AGL?

Shares outstanding
16.8M
Float
10.9M
Held by insiders
+5.0%
Held by institutions
+98.5%
Short interest (% of shares)
+8.5%
Days to cover
3.9

What does agilon health, Inc. do?

CEO
Mr. Timothy Patrick O'Rourke
Employees
856
Headquarters
Westerville, OH, United States

Updated Nov 6, 2026. Prices and fundamentals: Source: Twelve Data. Filings and insider trades: SEC EDGAR. Charts: TradingView Lightweight Charts. Educational information, not investment advice.